117 related articles for article (PubMed ID: 8551064)
41. Trace element content in breasts with fibrocystic disease.
Kanias GD; Kouri E; Arvaniti H; Karaiosifidi H; Kouneli S
Biol Trace Elem Res; 1994; 43-45():363-70. PubMed ID: 7710850
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical study of D5 antigen (an oestrogen receptor related protein) in normal breast, benign breast disease, and mammary carcinoma in situ.
Girling A; Caleffi M; King RJ; Millis RR
J Clin Pathol; 1988 Apr; 41(4):448-53. PubMed ID: 2835402
[TBL] [Abstract][Full Text] [Related]
43. Large-needle core biopsy in atypical intraductal epithelial hyperplasia including immunohistochemical expression of high molecular weight cytokeratin: analysis of results of a single institution.
Gal-Gombos EC; Esserman LE; Recine MA; Poppiti RJ
Breast J; 2002; 8(5):269-74. PubMed ID: 12199753
[TBL] [Abstract][Full Text] [Related]
44. [Morphogenetic potential of the communication systems in breast dysplasia and fibroadenoma].
Abrosimov SIu; Dorosevich AE; Golubev OA
Arkh Patol; 1996; 58(3):33-7. PubMed ID: 8967840
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.
Kostianets O; Antoniuk S; Filonenko V; Kiyamova R
Diagn Pathol; 2012 Nov; 7():161. PubMed ID: 23181716
[TBL] [Abstract][Full Text] [Related]
46. The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data.
Marrero D; Peralta R; Valdivia A; De la Mora A; Romero P; Parra M; Mendoza N; Mendoza M; Rodriguez D; Camacho E; Duarte A; Castelazo G; Vanegas E; Garcia I; Vargas C; Arenas D; Jimenez F; Salcedo M
J Clin Pathol; 2012 May; 65(5):419-23. PubMed ID: 22412049
[TBL] [Abstract][Full Text] [Related]
47. Cytokine pattern of the breast tumor supernatant.
Autenshlyus AI; Kunts TA; Karpukhina KV; Mikhaylova ES; Varaksin NA; Marinkin IO; Lyakhovich VV
Dokl Biol Sci; 2016 Sep; 470(1):247-248. PubMed ID: 27822759
[TBL] [Abstract][Full Text] [Related]
48. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma.
Arihiro K; Kaneko M; Fujii S; Inai K; Yokosaki Y
Breast Cancer; 2000 Jan; 7(1):19-26. PubMed ID: 11029766
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical demonstration of histone H1(0) in human breast carcinoma.
Kostova NN; Srebreva LN; Milev AD; Bogdanova OG; Rundquist I; Lindner HH; Markov DV
Histochem Cell Biol; 2005 Nov; 124(5):435-43. PubMed ID: 16158288
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB
Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246
[TBL] [Abstract][Full Text] [Related]
51. Circulating breast tumour antigen-sensitive T lymphocytes in early breast cancer and high risk benign breast disease.
Ramey WG; Hashim GA; Fitzpatrick HF
Br J Surg; 1979 Dec; 66(12):848-52. PubMed ID: 315807
[TBL] [Abstract][Full Text] [Related]
52. Tissue binding of lectins in disorders of the breast.
Franklin WA
Cancer; 1983 Jan; 51(2):295-300. PubMed ID: 6295598
[TBL] [Abstract][Full Text] [Related]
53. Localization of mucinous-like carcinoma associated antigen (MCA) in breast pathology: comparison with carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA).
Saccani Jotti G; Fontanesi M; Colombo A; Valtolina M; Tardini A
Int J Biol Markers; 1990; 5(3):145-52. PubMed ID: 2286779
[TBL] [Abstract][Full Text] [Related]
54. Autoradiographic demonstration of 3H-estradiol incorporation in benign human mammary lesions.
Buell RH; Tremblay G
Am J Clin Pathol; 1984 Jan; 81(1):30-4. PubMed ID: 6691303
[TBL] [Abstract][Full Text] [Related]
55. Invasive ductal carcinoma, fibroadenoma and adjacent breast stroma angiogenesis: an immunohistochemical and morphometrical study.
Da Silva ID; De Lima GR; Gebrim LH; Baracat FF; Focchi GR; Evncio Neto J; Simões MJ
Bull Assoc Anat (Nancy); 1996 Sep; 80(250):17-9. PubMed ID: 9127689
[TBL] [Abstract][Full Text] [Related]
56. [Methodological approaches to quantitative immunohistochemical evaluation of expression of breast apoptosis and proliferation markers].
Kostiuchek IN; Kogan IIu; Kvetnoĭ IM
Arkh Patol; 2006; 68(1):47-8. PubMed ID: 16544540
[TBL] [Abstract][Full Text] [Related]
57. H-cadherin expression in breast cancer.
Takeuchi T; Misaki A; Chen BK; Ohtsuki Y
Histopathology; 1999 Jul; 35(1):87-8. PubMed ID: 10383720
[No Abstract] [Full Text] [Related]
58. PLASMINOGEN AND ANGIOSTATIN LEVELS IN FEMALE BENIGN BREAST LESIONS.
Tykhomyrov AA; Vovchuk IL; Grinenko TV
Ukr Biochem J; 2015; 87(5):103-12. PubMed ID: 26717601
[TBL] [Abstract][Full Text] [Related]
59. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.
O'Connell JT; Shao ZM; Drori E; Basbaum CB; Barsky SH
Hum Pathol; 1998 Dec; 29(12):1517-23. PubMed ID: 9865841
[TBL] [Abstract][Full Text] [Related]
60. Microglandular adenosis with transition to breast carcinoma: a series of three cases.
Lin L; Pathmanathan N
Pathology; 2011 Aug; 43(5):498-503. PubMed ID: 21753716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
